Visual Field Reading Center to Lead Multisite Clinical Study

The University of Iowa has entered into a multi-year clinical study with drug developer Lundbeck, Inc. to evaluate a treatment alternative for patients experiencing refractory complex partial seizures due to Central Nervous System disorders.

The study will be led by the Visual Field Reading Center of the UI Department of Ophthalmology and Visual Sciences. Titled "A Prospective, Open-label Study of the Structure and Function of the Retina in Adult Patients with Refractory Complex Partial Seizures Treated with Vigabatrin (Sabril®), the study is valued at nearly $1.2 million. It will take place over a two-year period and involve other ophthalmology centers and eye care facilities around the country.

The Visual Field Reading Center provides clinicians and researchers a means to evaluate visual field data, including study design consultation, training of visual field testing, and interpretation and analysis of visual field data. More information about the Center at: http://vfrc.ophth.uiowa.edu.